Jens Juul Holst

Jens Juul Holst

Professor

ORCID: 0000-0001-6853-3805

Publication year:
All
1371 - 1380 out of 1,845Page size: 10
  1. 2004
  2. Published

    Gastric inhibitory polypeptide does not inhibit gastric emptying in humans

    Meier, J. J., Goetze, O., Anstipp, J., Hagemann, D., Holst, Jens Juul, Schmidt, W. E., Gallwitz, B. & Nauck, M. A., Apr 2004, In: American Journal of Physiology: Endocrinology and Metabolism. 286, 4, p. E621-5

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Glucagon-like peptide-2 inhibits antral emptying in man, but is not as potent as glucagon-like peptide-1

    Nagell, C. F., Wettergren, A., Pedersen, J. F., Mortensen, D. & Holst, Jens Juul, Apr 2004, In: Scandinavian Journal of Gastroenterology. 39, 4, p. 353-8 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Cholecystokinin inhibits gastrin secretion independently of paracrine somatostatin secretion in the pig

    Schmidt, P. T., Hansen, L., Hilsted, Linda & Holst, Jens Juul, Mar 2004, In: Scandinavian Journal of Gastroenterology. 39, 3, p. 217-21 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Incretins, insulin secretion and Type 2 diabetes mellitus

    Vilsbøll, T. & Holst, Jens Juul, Mar 2004, In: Diabetologia. 47, 3, p. 357-66 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes

    Meier, J. J., Weyhe, D., Michaely, M., Senkal, M., Zumtobel, V., Nauck, M. A., Holst, Jens Juul, Schmidt, W. E. & Gallwitz, B., Mar 2004, In: New Horizons (Baltimore). 32, 3, p. 848-51 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects

    Näslund, E., King, N., Mansten, S., Adner, N., Holst, Jens Juul, Gutniak, M. & Hellström, P. M., Mar 2004, In: The British Journal of Nutrition. 91, 3, p. 439-46 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Antihyperglycemic effects of stevioside in type 2 diabetic subjects

    Gregersen, S., Jeppesen, P. B., Holst, Jens Juul & Hermansen, K., Jan 2004, In: Metabolism. 53, 1, p. 73-6 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Additive effects of glucagon-like peptide 1 and pioglitazone in patients with type 2 diabetes.

    Olsen, Ane Mette Zander, Christiansen, A., Madsbad, Sten & Holst, Jens Juul, 2004, In: Diabetes Care. 27, 8, p. 1910-4 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Anti-hyperglycemi effects of stevioside in type 2 diabetic subjects

    Gregersen, S., Jeppesen, P. B., Holst, Jens Juul & Hermansen, K., 2004, In: Metabolism. 53, p. 73-76

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide-1

    Nauck, M. A., Walberg, J., Vethacke, A., El-Quaghlidi, A., Senkal, M., Holst, Jens Juul, Gallwitz, J. B., Schmidt, W. E. & Schmiegel, W., 2004, In: Regul. Pept.. 118, p. 89-97

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...134 135 136 137 138 139 140 141 ...185 Next

ID: 4207